WallStreetZenWallStreetZen

NASDAQ: SLNO
Soleno Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SLNO earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$28.4M
Current Profit Margin
0%

SLNO Return on Equity

Current Company
-280.2%
Current Industry
1.3%
Current Market
22.1%
SLNO's Return on Equity (-280.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SLNO announces earnings.

SLNO Return on Assets

Current Company
-104.4%
Current Industry
-1.5%
SLNO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SLNO Return on Capital Employed

Current Company
-128.46%
Current Industry
11.8%
SLNO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SLNO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SLNO$0.00-$26.16M-$28.45MN/AN/A
NUVB$0.00-$90.01M-$90.41MN/AN/A
MGTX$0.00-$102.48M-$124.54MN/AN/A
PMVP$0.00-$73.30M-$74.14MN/AN/A
ERAS$0.00-$232.17M-$235.72MN/AN/A
View Top Biotech Stocks

SLNO earnings dates

Next earnings date
Nov 7, 2023

Soleno Therapeutics Earnings & Revenue FAQ

What were SLNO's earnings last quarter?

On Invalid Date, Soleno Therapeutics (NASDAQ: SLNO) reported Q2 2023 earnings per share (EPS) of -$0.81, up 12.5% year over year. Total Soleno Therapeutics earnings for the quarter were -$8.48 million. In the same quarter last year, Soleno Therapeutics's earnings per share (EPS) was -$0.72.

If you're new to stock investing, here's how to buy Soleno Therapeutics stock.

What was SLNO's earnings growth in the past year?

As of Q4 2023, Soleno Therapeutics's earnings has grown year over year. Soleno Therapeutics's earnings in the past year totalled -$28.45 million.

What is SLNO's earnings date?

Soleno Therapeutics's earnings date is Invalid Date. Add SLNO to your watchlist to be reminded of SLNO's next earnings announcement.

What was SLNO's revenue last quarter?

On Invalid Date, Soleno Therapeutics (NASDAQ: SLNO) reported Q2 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Soleno Therapeutics's revenue was $0.00.

What was SLNO's revenue growth in the past year?

As of Q4 2023, Soleno Therapeutics's revenue has grown null year over year. Soleno Therapeutics's revenue in the past year totalled $0.00.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.